➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Colorcon
Dow
Johnson and Johnson
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Medimetriks Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MEDIMETRIKS PHARMS, and what generic and branded alternatives to MEDIMETRIKS PHARMS drugs are available?

MEDIMETRIKS PHARMS has eight approved drugs.



Summary for Medimetriks Pharms
US Patents:0
Tradenames:5
Ingredients:4
NDAs:8

Drugs and US Patents for Medimetriks Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medimetriks Pharms SYNALAR-HP fluocinolone acetonide CREAM;TOPICAL 016161-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Medimetriks Pharms LOPROX ciclopirox CREAM;TOPICAL 018748-001 Dec 30, 1982 AB RX Yes Yes   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide SOLUTION;TOPICAL 015296-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial
Medimetriks Pharms LOPROX ciclopirox SUSPENSION;TOPICAL 019824-001 Dec 30, 1988 AB RX Yes Yes   Start Trial   Start Trial
Medimetriks Pharms BETAXOLOL HYDROCHLORIDE betaxolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 075630-001 Apr 12, 2001 AT RX No No   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-002 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-004 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for MEDIMETRIKS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Gel 0.77% ➤ Subscribe 2006-05-10
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
Express Scripts
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.